245 related articles for article (PubMed ID: 38297320)
1. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
3. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract][Full Text] [Related]
4. Low
Xie Z; Chen N
Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
[TBL] [Abstract][Full Text] [Related]
5. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
7. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
9. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
10. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
Sun X; Liu P
Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
[TBL] [Abstract][Full Text] [Related]
11. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
[TBL] [Abstract][Full Text] [Related]
13. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
15. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
[No Abstract] [Full Text] [Related]
16. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.
Zhang J; Zhao Q; Huang H; Lin X
BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313
[TBL] [Abstract][Full Text] [Related]
18. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
20. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
